4-Octyl itaconate blocks GSDMB-mediated pyroptosis and restricts inflammation by inactivating granzyme A

Abstract

GSDMB-mediated pyroptosis facilitates a pro-inflammatory immune microenvironment and needs to be tightly regulated to avoid excessive inflammation. Here, we provide evidence that itaconate and its cell-permeable derivative 4-octyl itaconate (4-OI) can significantly inhibit GSDMB-rendered pyroptotic activity independent of Nrf2. 4-OI interferes proteolytic process of GSDMB by directly modifying Cys54, Cys148 and Ser212 on granzyme A (GrzA), a serine protease that site-specifically cleaves the inter-domain linker of GSDMB, instead of interaction with GSDMB, thereby blocking pyroptosis and exerts anti-inflammatory effects. Moreover, 4-OI alleviates inflammation by suppressing GSDMB-induced pyroptotic cell death during acute colitis models in intestinal epithelial GSDMB conditional transgenic mice. Our data expand the role of 4-OI as a crucial immunometabolic derivative that regulates innate immunity and inflammation through a newly identified posttranslational modification, and targeting of pyroptosis by 4-OI therefore holds potent therapeutic potential for primarily inflammatory and/or autoimmune diseases.

References

[1] ShiJ, GaoW, ShaoF. Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci. 2017; 42:245-254.

[2] LiuX, XiaS, ZhangZ, Wu H, LiebermanJ. Channelling inflammation: gasdermins in physiology and disease. Nat Rev Drug Discov. 2021; 20:384-405.

[3] BrozP, Pelegrín P, ShaoF. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2020; 20:143-157.

[4] ZhouZ, HeH, WangK, et al. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells. Science. 2020; 368: eaaz7548.

[5] ZhongX, ZengH, ZhouZ, et al. Structural mechanisms for regulation of GSDMB pore-forming activity. Nature. 2023; 616:598-605.

[6] WangC, Shivcharan S, TianT, et al. Structural basis for GSDMB pore formation and its targeting by IpaH7.8. Nature. 2023; 616:590-597.

[7] KongQ, XiaS, PanX, et al. Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis. Sci Immunol. 2023; 8: eadg3196.

[8] OltraSS, ColomoS, SinL, et al. Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells. Cell Death Differ. 2023; 30:1366-1381.

[9] HooftmanA, O’Neill LAJ. The immunomodulatory potential of the metabolite itaconate. Trends Immunol. 2019; 40:687-698.

[10] RuntschMC, Angiari S, HooftmanA, et al. Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages. Cell Metab. 2022; 34:487-501.e8.

[11] MillsEL, RyanDG, PragHA, et al. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature. 2018; 556:113-117.

[12] LiaoST, HanC, XuDQ, FuXW, WangJS, Kong LY. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects. Nat Commun. 2019; 10:5091.

[13] QinW, QinK, ZhangY, et al. S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate. Nat Chem Biol. 2019; 15:983-991.

[14] QinW, ZhangY, TangH, et al. Chemoproteomic profiling of itaconation by bioorthogonal probes in inflammatory macrophages. J Am Chem Soc. 2020; 142:10894-10898.

[15] HooftmanA, Angiari S, HesterS, et al. The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation. Cell Metab. 2020; 32:468-478.e7.

[16] LiW, LiY, KangJ, et al. 4-octyl itaconate as a metabolite derivative inhibits inflammation via alkylation of STING. Cell Rep. 2023; 42:112145.

[17] HansenJM, de Jong MF, WuQ, et al. Pathogenic ubiquitination of GSDMB inhibits NK cell bactericidal functions. Cell. 2021; 184:3178-3191.e18.

[18] RanaN, Privitera G, KondolfHC, et al. GSDMB is increased in IBD and regulates epithelial restitution/repair independent of pyroptosis. Cell. 2022; 185:283-298.e17.

[19] MurphyMP, O’Neill LAJ. Krebs cycle reimagined: the emerging roles of succinate and itaconate as signal transducers. Cell. 2018; 174:780-784.

[20] PeaceCG, O’Neill LA. The role of itaconate in host defense and inflammation. J Clin Invest. 2022; 132:e148548.

[21] HuJJ, LiuX, XiaS, et al. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol. 2020; 21:736-745.

[22] RathkeyJK, ZhaoJ, LiuZ, et al. Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Sci Immunol. 2018; 3: eaat2738.

[23] HumphriesF, Shmuel-Galia L, Ketelut-CarneiroN, et al. Succination inactivates gasdermin D and blocks pyroptosis. Science. 2020; 369:1633-1637.

[24] Hink-SchauerC, Estebanez-Perpina E, KurschusF, et al. Crystal structure of the apoptosis-inducing human granzyme A dimer. Nat Struct Biol. 2003; 10:535-540.

[25] GongW, YangK, ZhaoW, et al. Intestinal gasdermins for regulation of inflammation and tumorigenesis. Front Immunol. 2022; 13:1052111.

[26] BergsbakenT, FinkSL, CooksonBT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol. 2009; 7:99-109.

[27] GongW, ZhengT, GuoK, et al. Mincle/Syk signalling promotes intestinal mucosal inflammation through induction of macrophage pyroptosis in Crohn’s disease. J Crohns Colitis. 2020; 14:1734-1747.

[28] GongW, LiuP, ZhaoF, et al. STING-mediated Syk signaling attenuates tumorigenesis of colitis-associated colorectal cancer through enhancing intestinal epithelium pyroptosis. Inflamm Bowel Dis. 2022; 28:572-585.

[29] KimHW, YuAR, LeeJW, et al. Aconitate decarboxylase 1 deficiency exacerbates mouse colitis induced by dextran sodium sulfate. Int J Mol Sci. 2022; 23:4392.

[30] YangW, WangY, WangT, et al. Protective effects of IRG1/itaconate on acute colitis through the inhibition of gasdermins-mediated pyroptosis and inflammation response. Genes Dis. 2022; 10:1552-1563.

[31] BambouskovaM, Potuckova L, PaulendaT, et al. Itaconate confers tolerance to late NLRP3 inflammasome activation. Cell Rep. 2021; 34:108756.

[32] SwainA, Bambouskova M, KimH, et al. Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages. Nat Metab. 2020; 2:594-602.

RIGHTS & PERMISSIONS

2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.